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Four	Questions	Relevant	to	Optimal	Subgroup	Selection		We	will	consider	four	settings	that	may	be	of	interest	in	selecting	optimal	subgroups	for	treatment.	Stated	intuitively,	these	settings	are:		 1. Who	do	we	treat	if	resources	are	limited	so	that	we	can	only	treat	q%	of	the	population?	2. Who	do	we	treat	if	resources	are	not	limited	so	that	we	could	potentially	treat	everyone	and	are	simply	deciding	who	would	benefit	from	treatment?	3. Who	do	we	treat	if	resources	are	not	limited,	but	are	subject	to	costs	or	side	effects?	4. How	do	we	select	subgroups	to	maximize	the	“effect	heterogeneity”	across	subgroups?			We	will	address	each	question	in	turn.			
Setting	1.	Subgroup	selection	under	resource	constraints		First	let	us	suppose	that	due	to	some	form	of	resource	constraints	(e.g.	costs,	doses	available,	etc.),	we	are	only	able	to	treat	at	most	q%	of	the	population.	We	have	data	from	a	randomized	trial	of	treatment	A	where	we	have	collected	outcome	Y	and	pretreatment	covariates	C.	We	want	to	use	the	covariates	C,	and	the	outcome	data	from	our	randomized	trial	to	determine	a	treatment	rule	in	order	to	partition	the	
population	into	those	that	we	should	treat	so	as	to	maximize	the	expected	outcome	for	the	population,	subject	to	the	constraint	that	we	can	only	treat	q%	of	the	population.	Once	we	decide	on	these	two	sets,	T,	the	treated,	and	S,	the	untreated,	then	the	expected	outcome	for	the	population	under	this	treatment	rule	is:		 !"##E[Y|A=1,T]	+	(1- !"##)E[Y|A=0,S]	 	 	 	 	 (1)		In	other	words,	for	q%	of	the	population	we	get	the	average	outcome	under	treatment	for	the	subgroup	T	that	we	selected	for	treatment	and	for	(100-q)%	of	the	population	we	get	the	average	outcome	under	control	for	the	subgroup	S	that	we	selected	not	to	receive	treatment.		It	is	shown	in	the	eAppendix	that	if	we	knew	the	potential	outcomes,	Y1	and	Y0,	for	each	individual	in	the	population	then	the	optimal	treatment	rule	to	maximize	the	expected	outcome	for	the	population	would	simply	be	to	treat	those	for	whom	{Y1-Y0>k}	where	k	is	determined	so	that	exactly	q%	are	treated.	In	other	words,	if	we	knew	the	potential	outcomes	for	each	individual,	so	that	we	knew	the	actual	effect,	Y1-Y0,	of	treatment	for	each	individual,	we	would	simply	treat	the	q%	for	which	the	effect	of	treatment	itself	was	largest.	In	actual	fact	however,	we	do	not	know	both	potential	outcomes	for	every	individual	in	the	population.	We	only	have	our	randomized	trial	data,	our	outcomes	Y,	and	our	covariates	C.	So	we	want	to	use	C	to	partition	individuals	into	those	who	we	do	or	do	not	treat	to	maximize	outcomes.	It	is	again	shown	in	the	eAppendix	that	to	maximize	outcomes,	using	covariates	C,	the	optimal	treatment	rule	is	to	treat	those	with	covariate	values	c	such	that			{E[Y|A=1,C=c]-E[Y|A=0,C=c]>k}			where	the	cut-off	k	is	again	determined	so	that	exactly	q%	are	treated.	In	other	words,	the	optimal	treatment	rule	is	to	treat	the	q%	with	the	highest	expected	treatment	effect	conditional	on	their	covariates.	The	expected	treatment	effect	for	each	individual	conditional	on	their	covariates	is	something	that	can	be	estimated	from	the	data	in	a	randomized	trial	and	thus	this	treatment	rule	can	be	implemented	in	practice.	We	could,	for	example,	fit	regression	models	for	the	expected	outcome	under	treatment	E[Y|A=1,C=c]	and	under	control	E[Y|A=0,C=c],	(or,	more	directly,	their	difference)	conditional	on	covariates,	to	obtain	estimates.	In	the	next	section,	we	will	discuss	some	statistical	issues	relevant	to	implementing	this	in	practice.	However,	again,	it	can	be	shown,	that	the	best	we	can	do	in	terms	of	maximizing	outcomes	for	the	population	using	just	the	covariates	C	is	to	treat	those	with	the	highest	expected	treatment	effect,	E[Y|A=1,C=c]-E[Y|A=0,C=c],	conditional	on	their	covariates.	With	this	treatment	rule	the	expected	outcome	for	the	population	is	again	then	qE[Y|A=1,T]	+	(1-q)E[Y|A=0,S].		The	expected	outcome	under	the	treatment	rule	will	not	be	as	high	as	we	could	have	obtained	had	we	known	both	potential	outcomes	for	all	individuals,	but	again	this	is	the	best	we	can	do	with	the	measured	covariates	C.	We	could	compare	the	expected	
outcome	(1)	under	the	treatment	rule	to	what	we	would	obtain	if	we	simply	randomly	selected	q%	of	the	population	for	treatment,	in	which	case	we	would	have	an	expected	outcome	of:		 !"##E[Y|A=1]	+	(1- !"##)E[Y|A=0]	 	 	 	 	 	 	 (2)		How	much	better	we	do	under	the	treatment	rule	using	the	covariates	C	will	depend	in	part	on	how	predictive	the	measured	covariates	are	of	the	association	between	treatment	and	the	outcome	of	interest,	and	also	how	well	we	statistically	model	the	expected	outcomes	E[Y|A=1,C=c]	and	E[Y|A=0,C=c],	or,	more	directly,	their	difference.	We	could	compare	the	expected	population	outcomes	in	(1)	under	different	estimates	of	the	optimal	treatment	rule	using	different	modeling	techniques.	Again,	in	the	next	section	we	will	consider	issues	of	statistical	modeling.	Intuitively,	how	well	we	improve	on	the	outcomes	by	selecting	subgroups	for	treatment	using	covariates	C,	instead	of	randomly	allocating	treatment,	will	effectively	depend	on	how	well	we	can	use	the	covariates	C	and	statistical	modeling	to	predict	the	potential	outcomes.	i.e.	how	well	we	estimate	the	true	E[Y|A=1,C]-E[Y|A=0,C].			
















eAppendix for Selecting optimal subgroups for
treatment using many covariates
A. The Form of the Optimal Treatment Rule
Notation
LetA denote a binary treatment of interest, Y an outcome and C a set of measured baseline covariates. Let
Y1 and Y0 denote the potential outcomes for each individual under treatment levels 1 and 0 respectively.
Let the population of individuals be denoted by 
. We rst assume treatment A is randomized and
then consider treatment that may arise from an observational study. For simplicity in the next several
section, in order to give intuitive proofs, we will assume a nite population of individuals with no ties
at the cut-o¤ for the optimal treatment rule. See Luedtke and van der Laan (2015, 2016ab) for further
discussion of these cases without these conditions.
Context 1: Treatment Subgroup Selection Under Limited Resources
Suppose that due to limited resources we can only treat 100q% of the population. We will assume that
treatment is benecial for at least 100q% of the population i.e. P (Y1   Y0 > 0) > q. Otherwise, if we
know this in advance, the problem reduces to Context 2 described below. We desire to partition 
 into
sets S and T such that P (! 2 T ) = q so as to maximize the average outcome if all units in T were treated
and all units in S were untreated. In other words, we wish to identify S and T to solve:
argmaxS;T :S[T=
;S\T=;;P (!2T )=q[qE(Y1j! 2 T ) + (1  q)E(Y0j! 2 S)]:
In fact, choosing S and T to maximize the average outcome if all units in T were treated and all units
in S were untreated is equivalent to choosing S and T to maximize the treatment e¤ect heterogeneity
with 100q% in one group, as stated in the following proposition.
Proposition 1. The solution to
argmaxS;T :S[T=
;S\T=;;P (!2T )=q[qE(Y1j! 2 T ) + (1  q)E(Y0j! 2 S)]
is equivalent to the solution to
argmaxS;T :S[T=
;S\T=;;P (!2T )=q[E(Y1   Y0j! 2 T )  E(Y1   Y0j! 2 S)]:
Proof. We have that
argmaxS;T :S[T=
;S\T=;;P (!2T )=q[E(Y1   Y0j! 2 T )  E(Y1   Y0j! 2 S)]
= argmaxS;T :S[T=







;S\T=;;P (!2T )=q[E(Y1j! 2 T )  E(Y1j! 2 S)  E(Y0j! 2 T ) + E(Y0j! 2 S)
  q
1  qE(Y1j! 2 T ) 
1  q
1  qE(Y1j! 2 S) +
q
q











;S\T=;;P (!2T )=q[qE(Y1j! 2 T ) + (1  q)E(Y0j! 2 S)]:
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The solution to this maximization problem in fact takes a very simple form as stated in the next
proposition.
Proposition 2. The solution to
argmaxS;T :S[T=
;S\T=;;P (!2T )=q[E(Y1   Y0j! 2 T )  E(Y1   Y0j! 2 S)]
almost surely takes the form, for some , of T = f! 2 
 : Y1(!)   Y0(!) > g and S = f! 2 
 :
Y1(!)  Y0(!)  g.
Proof. We prove the result by contradiction. Suppose S and T were not of this form. Then there must
exist (possibly non-unique) disjoint sets 
0  T and 
  S of equal and positive probability such that
Y1(!
0) Y0(!0) < Y1(!) Y0(!) for all !0 2 
0 and ! 2 
. Let T 0 = (T[
)n
0 and S0 = (S[
0)n
.
Then E(Y1   Y0j! 2 T 0) E(Y1   Y0j! 2 S0) > E(Y1   Y0j! 2 T ) E(Y1   Y0j! 2 S) and thus S and T
would not be the solution to argmaxS;T :S[T=
;S\T=;;P (!2T )=q[E(Y1 Y0j! 2 T ) E(Y1 Y0j! 2 S)].
If both counterfactual outcomes were known for all individuals, then  could be obtained as the
solution to P (Y1 Y0 > ) = q and the average outcome for the population under the optimal treatment
rule of giving treatment if Y1   Y0 >  would be qE(Y1jY1   Y0 > ) + (1  q)E(Y0jY1   Y0  ). It is of
course not possible to partition individuals in this way without complete knowledge of the counterfactual
outcomes, which will in general not be available.
However, it is still possible to partition the covariate space to carry out a similar maximization. If we
let   denote the support of C the task becomes
argmaxS;T :S[T= ;S\T=;;P (C2T )=q[E(Y1   Y0j! 2 T )  E(Y1   Y0j! 2 S)]:
By arguments similar to those presented above, the solution to this takes the form of T = fc 2   :
E(Y jA = 1; c)   E(Y jA = 0; c) > kg i.e. the treatment rule is then simply give treatment to those for
whom E(Y jA = 1; c)  E(Y jA = 0; c) > k with k given as the solution toZ
1[E(Y1   Y0jC = c) > k]dP (c) = q:
In practice one must model E(Y jA = 1; C = c)  E(Y jA = 0; C = c) and estimate k.
The average outcome under this treatment rule is then given by q
Z
E(Y jA = 1; c)dP (cjC 2 T ) +
(1   q)
Z
E(Y jA = 0; c)dP (cjC =2 T ): Note that this average outcome will not in general be as high as
the average outcome under the optimal decision rule if both counterfactual outcomes were themselves
known for all individuals, in which case the average outcome would be given as above, qE(Y1jY1   Y0 >
) + (1  q)E(Y0jY1   Y0  ) where  is dened as the solution to P (Y1   Y0 > ) = q. The extent to
which the average outcome under the optimal treatment rule using the measured covariates C comes close
to that which could be obtained under complete knowledge of the counterfactual outcomes will depend
on the extent to which the covariates C are predictive of the outcome itself. Note that it is also thus of
course the case that the average outcome under the optimal treatment rule using data on the measured
covariates C will always be relative to C.
It may be of interest to compare the average outcome under this optimal treatment decision rule using
the measured covariates C to the average outcome with no one treated, E(Y jA = 0), the outcome with
100q% treated but selected randomly qE(Y jA = 1) + (1  q)E(Y jA = 0), and the average outcome with
everyone treated, E(Y jA = 1). It might also be of interest to compare the treatment e¤ect for those
treated under the optimal rule,
Z
fE(Y jA = 1; c)  E(Y jA = 0; c)gdP (cjC 2 T ), to those left untreated
by the rule
Z
fE(Y jA = 1; c)   E(Y jA = 0; c)gdP (cjC =2 T ), and also to the average treatment e¤ect
for the population E(Y jA = 1)   E(Y jA = 0). Another relevant metric may be taken as the di¤erence
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between the treatment e¤ects comparing those who are assigned treatment by the rule versus those who
are not: Z
fE(Y jA = 1; c)  E(Y jA = 0; c)gdP (cjC 2 T )
 
Z
fE(Y jA = 1; c)  E(Y jA = 0; c)gdP (cjC =2 T ):
This could be taken as a measure of e¤ect heterogeneity introduced by the optimal treatment rule for the
100q% to receive treatment. The analogous metric under treatment of a random 100q% of the population
selected for treatment would simply be 0.
Context 2: Unconstrained Treatment Subgroup Selection
Now suppose that resources are unconstrained and all could be treated who benet from treatment. The
optimal subgroup for treatment would then be
T = f! : Y1(!)  Y0(!) > 0g:
Once again, we cannot determine this subgroup as in general we will not have information on both
potential outcomes for all individuals. Instead, with covariate data on C, we would select the subgroup
to treat as those with covariates C such that the expected value of the treatment e¤ect conditional on C
was positive. Thus we would treat those with covariate values that lie in the set
T = fc 2   : E(Y jA = 1; c)  E(Y jA = 0; c) > 0g:
In practice with high dimensional C, the expectation E(Y ja; c) would have to be modeled. If we were
to follow this treatment rule, the average outcome under this rule would beZ
c2T
E(Y jA = 1; c)dP (c) +
Z
c=2T
E(Y jA = 0; c)dP (c):
Note that this average outcome will not in general be as high as the average outcome under the
optimal decision rule if both counterfactual outcomes were themselves known in which case the average
outcome would be E(Y1jY1   Y0 > 0)P (Y1   Y0 > 0) +E(Y0jY1   Y0  0)P (Y1   Y0  0). The extent to
which the average outcome under the optimal treatment rule using the measured covariates C comes close
to that which could be obtained under complete knowledge of the counterfactual outcomes will depend
on the extent to which the covariates C are predictive of the outcome itself. It is also thus of course the
case that the average outcome under the optimal treatment rule using data on the measured covariates
C will always be relative to C.
It may be of interest to compare this average outcome under the optimal treatment rule using the
measured covariates C to the average outcome with no one treated, E(Y jA = 0), and to the average
outcome with everyone treated, E(Y jA = 1). It might also be of interest to compare the treatment e¤ect
for those treated under the optimal rule
Z
fE(Y jA = 1; c)   E(Y jA = 0; c)gdP (cjC 2 T ), to those left
untreated by the rule
Z
fE(Y jA = 1; c) E(Y jA = 0; c)gdP (cjC =2 T ), and also to the average treatment
e¤ect for the population E(Y jA = 1)   E(Y jA = 0). Another relevant metric may be taken as the
di¤erence between the treatment e¤ects comparing those who are assigned treatment by the rule versus
those who are not:Z
fE(Y jA = 1; c)  E(Y jA = 0; c)gdP (cjC 2 T ) 
Z
fE(Y jA = 1; c)  E(Y jA = 0; c)gdP (cjC =2 T ):
This could be taken as a measure of e¤ect heterogeneity.
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Context 3: Unconstrained Treatment Subgroup Selection Under Costs or Side
E¤ects
Another generalization of Setting 1 that might be considered is a setting in which there is a cost constraint.
Typically this will require the investigator to only treat those with treatment e¤ect greater than some
threshold (c) that relies on the covariate value c. If all counterfactuals were known, we would use
individual-level treatment e¤ect Y1(!)  Y0(!), and we will show that this can be replaced by E(Y jA =
1; c) E(Y jA = 0; c) in the realistic setting where only one counterfactual is observed for each individual.




E(Y jA = 1; c)dP (c) +
Z
c62T




Cost(c)dP (c)  Cost Constraint;
where Cost() is pre-dened positive function giving the cost of treating someone in covariate strata
and Cost Constraint is the pre-dened constraint. The results in this section easily generalize to the
case where Cost(c) can equal zero, but we omit this case for simplicity. If b = E[Cost(C)] is less than
Cost Constraint then the constraint is not active and we revert to Context 2. Otherwise the T maximizing
the above objective takes the following form.
Proposition 3. If b is nite and greater than Cost Constraint, then the T maximizing the objective
function above takes the form, f! 2 
 : E(Y jA = 0; c)   E(Y jA = 0; c) > kCost(c)g, where k is the
solution to Z
1 [E(Y1   Y0jC = c) > kCost(c)] Cost(c)dP (c) = Cost Constraint :
Proof. Let Pc denote the probability measure with density dPcdP (c) = Cost(c)=b. Let
~Y = bY=Cost(C),
where we note that ~Y is a deterministic function of Y conditional on C = c so that bEP (Y jA =
a; c)=Cost(c) is equal to EP ( ~Y jA = a; c). We can write the mean outcome under the optimal rule
as Z
c2T
E( ~Y jA = 1; c)dPc(c) +
Z
c62T
E( ~Y jA = 0; c)dPc(c):
The cost constraint rewrites as Pc(C 2 T )  (Cost Constraint)=b. We are now in Context 1, so maximiz-
ing T takes the form f! 2 
 : E( ~Y jA = 0; c)  E( ~Y jA = 0; c) > ~kg, where ~k is the solution toZ
1
h
E( ~Y jA = 1; c)  E( ~Y jA = 0; c) > ~k
i
dPc(c) = (Cost Constraint)=b
Multiplying both sides by b, using the denition of ~Y , and letting k = ~k=b gives the result.
It may be of interest to compare this average outcome under the optimal treatment rule to the
average outcome with no one treated, E(Y jA = 0), and to the average outcome with everyone treated,
E(Y jA = 1). It might also be of interest to compare the treatment e¤ect for those treated under the
optimal rule,
Z
fE(Y jA = 1; c)   E(Y jA = 0; c)gdP (cjC 2 T ), to those left untreated by the ruleZ
fE(Y jA = 1; c)   E(Y jA = 0; c)gdP (cjC =2 T ), and also to the average treatment e¤ect for the
population E(Y jA = 1)  E(Y jA = 0).
Context 4: Treatment Subgroup Selection to Maximize Treatment E¤ect Het-
erogeneity
In examining subgroup analyses reported in the literature one is sometimes under the impression that
a central goal is to nd a subgroup division that maximizes e¤ect heterogeneity across the subgroups.
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While it is not clear that this goal is of principal policy importance, it can be carried out using a set of
measured covariates C. The task could then be stated as nding a partition of individuals into sets T
and S to maximize treatment e¤ect heterogeneity when comparing the treatment e¤ects among those in
T versus S. The problem could thus formally be stated as
argmaxS;T :S[T=
;S\T=;[E(Y1   Y0j! 2 T )  E(Y1   Y0j! 2 S)]:
The solution to this maximization problems takes a relatively simple form as in the next Proposition.
Proposition 4. The solution to
argmaxS;T :S[T=
;S\T=;[E(Y1   Y0j! 2 T )  E(Y1   Y0j! 2 S)]
takes the form, for some , of T = f! 2 
 : Y1(!)  Y0(!) > g and S = f! 2 
 : Y1(!)  Y0(!)  g.
Proof. The proof is similar to that of Proposition 2 above.
If we let V = Y1   Y0 and let p(v) denote the density of V . To determine , we wish to choose  to






















































P (V  )2 f p()P (V > ) + p()
Z 1
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P (V  )2 f P (V > ) +
Z 1





The solution to the equation gives  which could be obtained numerically.
The treatment rule that maximizes e¤ect heterogeneity is then either T = f! 2 
 : Y1(!) Y0(!)  g
or T = f! 2 
 : Y1(!)   Y0(!) > g. The maximum treatment e¤ect heterogeneity that can thus be
obtained comparing two subgroups that partition all individuals is thus E(Y1 Y0jY1 Y0 > ) E(Y1 
Y0jY1   Y0  ).
It is of course not possible to partition individuals in this manner without complete knowledge of the
counterfactual outcomes. However, it is still possible to carry out a similar partitioning using measured
covariates C. If we let   denote the support of C, the task becomes
argmaxS;T :S[T= ;S\T=;[E(Y1   Y0jC 2 T )  E(Y1   Y0jC 2 S)]:
By arguments similar to those presented above, the sets S and T are then given by T = fc 2   : E(Y jA =
1; c)   E(Y jA = 0; c) > kg and S = fc 2   : E(Y jA = 1; c)   E(Y jA = 0; c)  kg for some k, and once
again k could be solved for numerically.
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The e¤ect heterogeneity under this treatment rule for maximizing e¤ect heterogeneity with measured
covariates C is then given by:Z
fE(Y jA = 1; c)  E(Y jA = 0; c)gdP (cjC 2 T ) 
Z
fE(Y jA = 1; c)  E(Y jA = 0; c)gdP (cjC =2 T ):
Note that this measure of e¤ect heterogeneity will not in general be as high as the maximum e¤ect
heterogeneity if both counterfactual outcomes for all individuals were known, which was given above as
E(Y1 Y0jY1 Y0  ) E(Y1 Y0jY1 Y0 < ). The extent to which the maximum e¤ect heterogeneity
under the treatment rule using the measured covariates C comes close to the maximum which can be
obtained under complete knowledge of the counterfactual outcomes will depend on the extent to which
the covariates C are predictive of the outcome itself. Note that it is also thus of course the case that
the maximum e¤ect heterogeneity under the treatment rule using data on the measured covariates C will
always be relative to C. It might also be of interest to compare the treatment e¤ect for those treated
under the maximizing rule,
Z
fE(Y jA = 1; c)   E(Y jA = 0; c)gdP (cjC 2 T ), to those left untreated by
the rule
Z
fE(Y jA = 1; c) E(Y jA = 0; c)gdP (cjC =2 T ), and also to the average treatment e¤ect for the
population E(Y jA = 1)  E(Y jA = 0).
If using the treatment rule that maximizes e¤ect heterogeneity, one can also estimate the average
outcome under this rule asZ
c2T
E(Y jA = 1; c)dP (c) +
Z
c=2T
E(Y jA = 0; c)dP (c):
One could compare this to the average outcome with no one treated, E(Y jA = 0), and the average
outcome with everyone treated, E(Y jA = 1). Note, however, this average outcome under the treatment
rule that maximizes e¤ect heterogeneity will in general be lower than the average outcome under the
treatment rule that maximizes the average outcome itself as discussed in Context 2. It is thus not clear
that this treatment rule that maximizes e¤ect heterogeneity is of particular use in policy-making, unlike
contexts 1, 2 and 3 above.
Further Comments on Observational Studies
The above approaches and results for randomized treatment A apply also to observational studies in which
the covariates C su¢ ce to control for confounding of the e¤ect of A on Y but, when reference is made
to the average outcome when no one is treated, E(Y jA = 0) must be replaced by
Z
E(Y jA = 0; c)dP (c);
when reference is made to the average outcome when everyone is treated, E(Y jA = 1) must be replaced
by
Z
E(Y jA = 1; c)dP (c); and when reference is made to the average treatment e¤ect for the population
E(Y jA = 1)  E(Y jA = 0) must be replaced by
Z
E(Y jA = 1; c)dP (c) 
Z
E(Y jA = 0; c)dP (c).
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B. Statistical Estimation
Supose we observe an i.i.d. sample (C1; A1; Y1); : : : ; (Cn; An; Yn) of observations generated according to
a randomized trial. We now consider estimation of the parameter from Context 2 in this setting. All of
these estimation problems rely on the user having an estimate of the conditional average treatment e¤ect
(CATE), i.e. the function mapping rom a covariate c to E[Y jA = 1; c]   E[Y jA = 0; c]. We therefore
start by presenting an estimation procedure for this quantity, and then proceed to give an overview of
estimation for Contexts 1 and 2. A specic estimation procedure for Contexts 1 and 2 can be found in
the eAppendix.
Estimation of the Conditional Average Treatment E¤ect
We frame the estimation of the CATE as a regression problem, which thereby enables both the use
of classical linear regression approaches and also any machine learning algorithm which is designed to
estimate a conditional mean function.




P (A = ajC = c) [y   f(a; c)] + f(1; c)  f(0; c);
where we recall that the probability of treatment given covariates is known in our randomized trial setting.
We use ~Y1; : : : ; ~Yn to denote the corresponding random variable for our trial participants and ~Y to denote
the general random variable corresponding to (C;A; Y ). We will provide guidance on the selection of f




C = ci = E[Y jA = 1; c]  E[Y jA = 0; c]:
This justies the following estimation procedure for the CATE function:
1. Dene pseudo-observations ~Y1; : : : ; ~Yn.
2. Regress ( ~Y1; : : : ; ~Yn) against (C1; : : : ; Cn) using a preferred regression algorithm.
Suppose for simplicity than one restricts oneself to least squares regression techniques for the latter step
(possibly subject to some complexity penalty). The class of such techniques is far richer than the classical
linear regression techniques: for example, generalized additive models, kernel smoothers, and smoothing
splines can all be t using this criterion (Hastie et al., 2002). The estimate for the CATE resulting from
the above will typically provide a mean-square consistent estimate if the regression algorithm is correctly
specied, and otherwise one can still measure the quality of a given estimate using mean-squared error
(MSE). Furthermore, if one has two correctly specied regression algorithms so that both have MSE
converging to zero with sample size, then typically the MSE of the simplerestimator decays at a faster
rate. As a simple example, a correctly specied univariate linear regression will typically have smaller
MSE than a correctly specied random forest regression in nite samples.
Committing to a single regression algorithm in the second step above is therefore unadvisable: ideally
one wants to select the simplest estimator which is (nearly) correctly specied so that the MSE is small for
the nite sample, but doing so a priori is not generally possible. To overcome this di¢ culty, we propose
the use of the ensemble algorithm known as super-learning (van der Laan, 2007). This algorithm allows the
user to input a library of candidate regression algorithms and outputs the t from a convex combination
of the candidate algorithms. This convex combination is selected to minimize the cross-validated MSE
between ~Y and the t. The super-learner algorithm is optimal in the sense that the cross-validated MSE
of the resulting t is at least as good as the cross-validated MSE of the best algorithm in the library (up
to a small remainder term). The usefulness of this nite sample result has been repeatedly supported
by simulations in the literature (cf. Polley and van der Laan, 2010; van der Laan and Rose, 2011). See
Luedtke and van der Laan (2014) for theoretical foundations and simulation results specic to the CATE.
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We conclude by discussing the selection of the function f . As the described method is valid for any
xed function f , one can set f equal to the constant function zero so that the pseudo-outcome takes on
a simple form. Though appealing for its simplicity, this choice of f will generally yield a suboptimal t
of the CATE. Given that it is typically easier to t a regression when the conditional variance of the
outcome given covariates is smaller, one may wish to choose f to make this quantity small. The choice
of f which minimizes this quantity is given by f(a; c) = E[Y ja; c]. In practice E[Y ja; c] is not known,
but typically substituting an estimate E^[Y ja; c] will perform better than choosing f equal to zero (see
Luedtke and van der Laan (2014) for a deeper discussion, and a double robustness based justication for
selecting f in this way that will prove useful in observational studies).
Estimates for Contexts 1 and 2
In the eAppendix we provide estimates for the parameters arising in Contexts 1 and 2 given an i.i.d.
sample (C1; A1; Y1); : : : ; (Cn; An; Yn) generated from a randomized trial. We propose using the cross-
validated targeted minimum loss-based estimation (CV-TMLE) framework to estimate these quantities.
This framework allows the user to provide initial estimates of the outcome regression E[Y ja; c] and the
CATE, where we do not require that the CATE estimate is equal to the di¤erence of outcome regressions
at A = 1 and A = 0. We advise using the super-learner methodology for the CATE discussed in the
previous section, and a standard regression-based super-learner for the outcome regression, regressing Y
against treatment and covariates.









E^[Y j1; Ci]  E^[Y j0; Ci]

;
where n = 0 for Context 1 and n is the cuto¤ estimated from the data for Context 2. Unfortunately,
this estimate will tend to be too biased for the parameter of interest, thereby making root-n rate inference
impossible. For intuition we will rst discuss the non-cross-validated TMLE procedure, and then discuss
how the CV-TMLE procedure di¤ers. The TMLE procedure confronts this challenge by uctuating the
initial outcome regression estimate E^[Y ja; c] with a univariate submodel selected to reduce the bias of the
above substitution estimator for the parameter of interest. Though a thorough description of the selected
submodel is beyond the scope of this manuscript, we invite readers to explore Luedtke and van der Laan
(2015) and van der Laan and Luedtke (2014) for the justication of the submodels used in Contexts 1










E^[Y j1; Ci]  E^[Y j0; Ci]

Though one can establish regularity conditions under which the bias is asymptotically negligible, it is
di¢ cult to establish reasonable conditions exerting control over the nite sample bias of this estimator,
especially in Context 2 where we are attempting to make inference on a quantity that the true CATE
maximizes over. Though we may use a di¤erent criteria function to estimate the CATE, this estimator
will still be prone to positive bias in nite samples. This positive bias manifests itself similarly to the
negative bias that results when one attempts to estimate the squared error between an outcome Y and
estimated regression function E^[Y jX] using the empirical squared error.
A natural solution to this nite sample bias issue is to use cross-validation. In the appendix we
present a cross-validated form of the TMLE algorithm for which this bias should not appear. Under a
mild consistency condition, our nal estimator  ^ of the parameters  from Context 1 satises the identity











I(\CATEv(C) > 0)  I(E[Y j1; C]  E[Y j0; C] > 0)

(E[Y j1; C]  E[Y j0; C])
i
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for a xed function D0, where each \CATEv is an estimate of the CATE t on 9/10 of the data and the
approximation holds up to a remainder term that shrinks to zero faster than n 1=2 in probability. If
the second term on the right is negligible, then we can develop standard Wald-type condence intervals
for the parameter of interest using the central limit theorem. Theorem 8 in Luedtke and van der Laan
(2016) shows that the second term on the right is indeed su¢ ciently small under a variety of assumptions
on the rate of convergence of the estimate of the CATE, one of which is a condition on its MSE. A
similar expansion holds for Context 2, though we omit it for brevity (see Luedtke and van der Laan
(2015) for details). Finally, we observe that the second term on the right-hand side above is nonpositive.
Hence, even if this term fails to be su¢ ciently small to be asymptotically negligible, our estimator for
the parameter of interest will at worst be negatively biased. One can further show that this implies to
establish the asymptotic validity of the lower bound of our condence interval regardless of the quality
of our estimate of the CATE.
Super-Learner for the Conditional Average Treatment E¤ect
The super-learner algorithm for this estimation problem is given below. For simplicity we use ten-fold
cross-validation and assume that the sample size n is a multiple of ten. We suppose that the user has m
candidate regression algorithms.
1. Dene pseudo-observations ~Y1; : : : ; ~Yn.
2. For v in f1; : : : ; 10g:
(a) For ` in f1; : : : ;mg:
 Fit candidate algorithm ` on observations

(Ci; ~Yi) : i 62
n
(v 1)n





ate the regression function estimate that takes as input c and outputs E^`v[ ~Y jc].
(b) For i in
n
(v 1)n




, deneXCVi to be them-length column vector

E^`v[ ~Y jci] : ` = 1; : : : ;m

.







4. For ` in f1; : : : ;mg:
 Fit the candidates ` on all of the observations, yielding a function which takes as input c and
outputs E^`[ ~Y jc].
5. Return the function b^ dened by b^(c) = nX(c), whereX(c) is the column vector

E^`[ ~Y jc] : ` = 1; : : : ;m

.
Estimator for Contexts 1 and 2
We now present a cross-validated targeted minimum loss-based estimator (CV-TMLE) for Contexts 1
and 2. We omit the derivation of this estimator from this work for brevity, and instead refer the reader
to references given in the main text for the derivation of CV-TMLEs for a nearly identical parameters
as in Contexts 1 and 2. We assume that the outcome Y is bounded, and without loss of generality we
assume that the lower bound is 0 and the upper bound is 1.
For simplicity, we use ten-fold cross-validation and assume that the sample size n is a multiple of ten.
For each v = 1; : : : ; 10, we let Tv denote the observations (Ci; Ai; Yi) with indices i 62
n
(v 1)n





i.e. the observations included in the training sample for a given cross-validation split. We also let v(i)
denote the v such that i 62
n
(v 1)n




, i.e. the cross-validation index for which i is not in the
training sample.
1. For v in f1; : : : ; 10g:
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(a) Obtain an estimate E^v[Y j] of the function mapping from (a; c) to E[Y ja; c] using observations
in Tv.
(b) Obtain an estimate b^v of the CATE function using observations in Tv.
Note: b^v(c) need not equal E^[Y jA = 1; c]  E^[Y jA = 0; c].






1(b^v(i)(c) > )  q:








logit E^v(i)[Y jAi; Ci] : i = 1; : : : ; n






: i = 1; : : : ; n

.
Note: The glm function in R will run a logistic regression on any outcome bounded in [0; 1].











sent the uctuated estimate of E[Y ja; c].
5. Let  ^ = 1n
Pn
i=1 1(b^v(i)(Ci) > n)
h
Qv(i)(1; Ci)  Qv(i)(0; Ci)
i
.
6. Let Di = 2Ai 1P (AijCi)
h
Yi   Qv(i)(Ai; Ci)
i








1(b^v(i)(Ci) > n) [Di   n] + nq
i2
;
where we take q = 1 in Context 2.
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